Jonathan Rothberg Email and Phone Number
Jonathan Rothberg work email
- Valid
- Valid
- Valid
- Valid
- Valid
Jonathan Rothberg personal email
- Valid
Jonathan Rothberg phone numbers
Over a Billion Dollars for Current Class of 4Catalyzer Startups.If you want to do the best work of your life, are truly gifted in Molecular evolution, molecular biology, deep learning, mixed signal IC design, or programming please email joinus@4catalyzer.com.Dr. Rothberg awarded by President Obama the National Medal of Technology for invented massively parallel DNA sequencing (NextGen), bringing it to market first, sequencing the first personal genome (Jim Watson), inventing semiconductor sequencing, sequencing first on a semiconductor chip (Gordon Moore Genome), leading the team that sequenced Neanderthal Genome (with Svante Paabo), and elucidating the extent of individual human variation. The New England Journal described Dr. Rothberg's sequencing innovation as enabling "The New Age of Molecular Diagnostics..." - recognized by Science magazine as one of the top 10 breakthroughs for 2007 & 2008. Developed Glembatumumab Vedotin a promising drug for Breast Cancer. Dr. Rothberg was born in 1963 in New Haven, Connecticut. He earned a B.S. in chemical engineering from Carnegie Mellon University and Ph.D. in biology from Yale University. Winner of The Wall Street Journal's Gold Medal for Innovation, and Nature Method's first Method of the year award, Dr. Rothberg's scientific work has been featured on the covers of Cell, Science, and Nature. Dr. Rothberg is the first person ever to be named four times as a World Economic Forum Technology Pioneer, is a member of the National Academy of Engineering, The Connecticut Academy of Science and Engineering, and was named a Life Trustees of Carnegie Mellon University. For his invention of massively parallel DNA sequencing he is the recipient of the 2010 Connecticut Medal of Technology, the Biochemical Analysis Prize for 2011 from the DGKL, was awarded an Honorary Doctor of Science from Mount Sinai School of Medicine, and was personally bestowed the National Medal of Technology by President Obama in May of 2016.Specialties: Founding Companies, sequencing human genomes, solving mysteries from honey bees to Neanderthal, inventing new technologies, financing and bringing novel innovations to the market. Enjoy working with scientists and engineers across diverse fields including semiconductors, nanotechnology, chemistry, physics, chemical engineering, material science, computer science, molecular biology and medicine.
Quantum-Si
View-
Founder And ChairmanQuantum-Si Dec 2015 - PresentBranford, Ct, Us
-
Founder, Chairman, Product ArchitectButterfly Network, Inc. Jan 2011 - PresentBurlington, Massachusetts, UsIf you program like John Carmack, do electronics like Steve Wozniak or design ICs like Federico Faggin please email careers@butterflynetinc.com. -
Founder And ChairmanHyperfine Feb 2014 - PresentGuilford, Connecticut, Us -
Founder And Chairman4Catalyzer Jan 2014 - PresentGuilford, Ct, Us4Catalyzer is a biotechnology accelerator founded by Dr. Rothberg, which has launchedButterfly Network (NYSE: BFLY), Quantum-Si (NASDAQ: QSI), Hyperfine andLiminal Sciences (NASDAQ: HYPR), Detect, Al Therapeutics, Tesseract, and ProteinEvolution. All of the 4Catalyzer companies are transforming 21st century medicineand improving our planet by solving today’s most challenging problems across lifescience research tools, medical devices, therapeutics and the environment.To learn more, visit: 4Catalyzer.com -
Founder And ChairmanDetect Jul 2018 - PresentGuilford, Ct, Us -
Founder And ChairmanIdentifeye Health Sep 2015 - PresentGuilford, Ct, Us -
Founder And ChairmanAi Therapeutics Jul 2013 - PresentGuilford, UsIf you do biochemistry like Arthur Kornberg, chemistry like Linus Pauling, genetics like Barbara McClintock and molecular biology like Richard Roberts please email jobs@lamthera.com. -
Adjunct Professor Of Genetics, Yale School Of Medicine.Yale School Of Medicine Jul 2015 - PresentNew Haven, Ct, UsLooking for interns & gifted students. Projects including deep learning, IC design, molecular evolution. Love people that have have been building electronic devices since junior high. -
Founder, Chairman, Cto And CeoIon Torrent By Life Technologies Oct 2007 - Oct 2010South San Francisco, Ca, UsInvented first Semiconductor chip for DNA sequencing and published in Nature the first post-light genome. Won the 2010 Connecticut Medal of Technology for inventing the first Semiconductor based DNA sequencing technology. Decoded the genome of Gordon Moore of Moore's law fame and published it in Nature. I sold Ion to Life Technologies for $725 Million in October 2010, and was recognized as a 2011 World Economic Forum Technology Pioneer - becoming the first person to win three times. Epilogue:In April of 2013 Thermo Fisher agreed to acquire Life Technologies for $13.6 billion with independent analysts valuing Ion Torrent at $2.4 billion. Bidders were after the "crown jewel" - Ion's semiconductor sequencing technology - for its potential to transform healthcare. Preceding the Thermo purchase my team established the Ion franchise as the best selling sequencing instruments in the world, created a bioinformatics platform for researchers and clinicians, launched the first system designed to enable the $1,000 genome, invented a revolutionary sample prep method, and launched the first "killer app" of DNA sequencing - the ability for clinicians to grab just the genes you want out of the genome. -
Founder, Chairman And Founding CeoRaindance Technologies 2004 - 2009Billerica, Ma, UsFounded, Incorporated, created SAB with 3 Nobel Prize winners, financed company, set vision: "a Raindance personal laboratory system in every lab" and invented their first killer "app" for genomics using droplet based fluidics. First droplet based fluidics company. Brought together technology to make the first universal laboratory instrument- the laboratory on-a-chip equivalent of the personal computer. 2008 World Economic Forum Technology Pioneer. Sold to BioRad in 2017. -
Co-Founder & ChairmanClarifi 1999 - May 2007UsFounded company as social networking site for financial investors with Michael Rothberg, and Gioel Molinari. Company found success as leading provider of quantitative analysis and risk management software to hedge and mutual funds. In May of 2007 Standard & Poor's the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research, data, and valuation acquired Clarifi. Gioel Molinari became managing director of the Clarifi division. We celebrated success after the closing at the 21 club in New York city.Epilogue:ClariFi's systems became the workhorse of major financial houses around the world ... And then everything crashed in October of 2008. Ok just kidding. Or am I. -
Founder, Chairman, Cto & Founding Ceo454 Life Sciences Jul 1999 - Sep 2006Branford, Ct, UsFirst next generation sequencing company and first to market. I invented massively parallel DNA sequencing while on paternity leave and created 454 to commercialize it. Invented first all in vitro cloning for next-generation sequencing based on cloning by limited dilution, assembled team, financed, put in place collaborations and key sites including Broad, Venter, Baylor. Won Wall Street Journal Gold Medal for best innovation, R&D Magazine Top 100 Innovations, selected as World Economic Forum Technology Pioneer. Initiated Neanderthal genome project, first deep cancer sequencing, early detection of drug resistant HIV strains, and the first sequencing of an individual Human Genomes (James Watson). Started the personal genome and precision medicine fields. Developed technology and lead team at 454 that uncovered potential cause of disappearance of honeybee, the first global characterization of structural variations in the human genome, and uncovered virus killing transplant patients; work twice recognized as Top 10 breakthroughs of the year by Science Magazine. 454 had almost everything, invented and owned the market, did the key experiments that changed how cancers are diagnosed. And then I woke up one morning to learn it was sold and I was out of a job. Epilogue:The massively parallel sequencing by synthesis and cloning by limited dilution for sample prep invented by me and my team at 454 formed the basis of all major competing technologies. The experiments we did first on deep-sequencing especially of cancers became the basis of all modern cancer diagnostics. Next generation sequencing is now a multibillion dollar industry. I remain the only person in the world that knows what "454" stands for. -
Founder, Chairman & CeoCuragen Corporation 1993 - 2004UsFounded CuraGen in my basement as first genomics company. Brought company public in 1998, one of the best performing stocks on the Nasdaq in 1999. Was exciting to see our Market Cap exceed American Airlines - $5 billion! Raised all financing, over $600 million, developed the technology and clinical pipeline. Established one of the most comprehensive intellectual property porfolios around the human genome. Conceived of and executed first systematic production of fully-human monoclonal antibodies against genomic targets. Got covers of Nature and Science for first global proteomics maps. Architect of strategy and initiated all major collaborations including Genentech, Biogen, Pioneer Hybrid/Dupont, Abgenix/Amgen, Roche, Glaxo, and Seatle Genetics. Invented massively parallel DNA sequencing while on paternity leave, financed, and set up 454 as a separately operating company under my direction to allow CuraGen to focus on Drug Pipeline, and 454 to become the first to market in next generation (massively parallel) sequencing, and world leader in genome sequencing. Left CuraGen with a clinical program, and a full pipeline consisting of 11 fully owned, fully-human, monoclonal antibodies for cancer and autoimmune disorders, incredible cash position ($300mm+), license to at cost access to 454 sequencing as a competitive advantage, and tremendous asset in 66% ownership of 454 corporation to allow additional funding of CuraGen pipeline. Discovered targets for (with my Wife Bonnie Rothberg) and developed CDX-011 a Antibody drug conjugate (ADC) now in Phase II clinical trials for Breast Cancer and Melanoma, and CDX-014 an ADC for Ovarian and renal Cancer. Proud of inventing the first open gene expression method, and using it to discover the target, and develop the first potential therapeutic for triple negative breast cancer (Glembatumumab vedotin).
Jonathan Rothberg Skills
Jonathan Rothberg Education Details
-
Carnegie Mellon UniversityChemical Engineering -
Yale UniversityMolecular Biology
Frequently Asked Questions about Jonathan Rothberg
What company does Jonathan Rothberg work for?
Jonathan Rothberg works for Quantum-Si
What is Jonathan Rothberg's role at the current company?
Jonathan Rothberg's current role is #ThanksObama - email joinus@4Catalyzer.com to help save the life of someone you love. Follow me on Twitter @JMRothberg.
What is Jonathan Rothberg's email address?
Jonathan Rothberg's email address is jr****@****gen.com
What is Jonathan Rothberg's direct phone number?
Jonathan Rothberg's direct phone number is +120345*****
What schools did Jonathan Rothberg attend?
Jonathan Rothberg attended Carnegie Mellon University, Yale University.
What are some of Jonathan Rothberg's interests?
Jonathan Rothberg has interest in Understanding How Life Began, Our Universe, At The End Of The Day, Consciousness, Science And Technology.
What skills is Jonathan Rothberg known for?
Jonathan Rothberg has skills like Genomics, Dna Sequencing, Bioinformatics, Genetics, Molecular Biology, Life Sciences, Drug Discovery, Biochemistry, Start Ups, R&d, Biotechnology, Sequencing.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial